These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29444164)
1. Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma. Praktiknjo M; Krabbe V; Pohlmann A; Sampels M; Jansen C; Meyer C; Strassburg CP; Trebicka J; Gonzalez Carmona MA PLoS One; 2018; 13(2):e0192897. PubMed ID: 29444164 [TBL] [Abstract][Full Text] [Related]
2. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053 [TBL] [Abstract][Full Text] [Related]
3. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Gordic S; Ayache JB; Kennedy P; Besa C; Wagner M; Bane O; Ehman RL; Kim E; Taouli B Abdom Radiol (NY); 2017 Jun; 42(6):1685-1694. PubMed ID: 28154910 [TBL] [Abstract][Full Text] [Related]
4. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis. Vestito A; Dajti E; Cortellini F; Montagnani M; Bazzoli F; Zagari RM Ultraschall Med; 2023 Jun; 44(3):e139-e147. PubMed ID: 34758491 [TBL] [Abstract][Full Text] [Related]
5. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. Lee YR; Park SY; Kim SU; Jang SY; Tak WY; Kweon YO; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Hur K J Gastroenterol Hepatol; 2017 May; 32(5):1079-1086. PubMed ID: 27859615 [TBL] [Abstract][Full Text] [Related]
6. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization. Koh YH; Choi JI; Kim HB; Kim MJ Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966 [TBL] [Abstract][Full Text] [Related]
7. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512 [TBL] [Abstract][Full Text] [Related]
8. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone. Kim JH; Kim PN; Won HJ; Shin YM AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154 [TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients. Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900 [TBL] [Abstract][Full Text] [Related]
10. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes. Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691 [TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785 [TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study. Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022 [TBL] [Abstract][Full Text] [Related]
16. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma. El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283 [TBL] [Abstract][Full Text] [Related]
17. Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation. Yoon JS; Lee YR; Kweon YO; Tak WY; Jang SY; Park SY; Hur K; Park JG; Lee HW; Chun JM; Han YS; Lee WK Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1230-1236. PubMed ID: 29794814 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection. Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995 [TBL] [Abstract][Full Text] [Related]
19. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Chang NK; Shin SS; Kim JW; Kim HJ; Jeong YY; Heo SH; Kim JK; Kang HK Korean J Radiol; 2012; 13 Suppl 1(Suppl 1):S104-11. PubMed ID: 22563280 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe. Lee BC; Liu KL; Wu CH; Huang KW; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH; Liang PC Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1699-1707. PubMed ID: 29946941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]